Lv11
8 积分 2023-11-17 加入
Safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-2010, a novel anti-MASP-2 antibody, in healthy volunteers: a randomized, double-blind, placebo-controlled phase 1 study
5小时前
已完结
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
17天前
已完结
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study
29天前
已完结
Population Pharmacokinetic/Pharmacodynamic Analysis of the Glucokinase Activator PB201 in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus: Facilitating the Clinical Development of PB201 in China
29天前
已完结
葡萄糖激酶基因突变导致的单基因糖尿病诊治专家共识
29天前
已完结
Bleximenib Dose Optimization and Determination of RP2D from a Phase 1 Study in Relapsed/Refractory Acute Leukemia Patients with KMT2A and NPM1 Alterations
1个月前
已关闭
Ziftomenib in relapsed/refractory (R/R) NPM1 -mutant acute myeloid leukemia (AML): Phase 1b/2 clinical activity and safety results from the pivotal KOMET-001 study
1个月前
已关闭
Menin inhibitors for adult acute myeloid leukemia: 2025 update
1个月前
已完结
皖公网安备34019202002308
